docetaxel

You have access
Clinical Outcome and Prognostic Variables of Second-line Therapy for Patients With Castration-resistant Prostate Cancer After Failure of First-line Androgen Receptor Axis-targeted Therapy
MOTOHIRO FUJIWARA, RYO FUJIWARA, TOMOHIKO OGUCHI, YOSHINOBU KOMAI, NOBORU NUMAO, SHINYA YAMAMOTO, JUNJI YONESE and TAKESHI YUASA

Anticancer Research April 2022, 42 (4) 2123-2130; DOI: https://doi.org/10.21873/anticanres.15694
Open Access
Efficacy of New Therapies for Relapse After Docetaxel Treatment of Bone Metastatic Castration-resistant Prostate Cancer in Clinical Practice
ATSUSHI MIZOKAMI, KOSHIRO NISHIMOTO, HIDEYASU MATSUYAMA, TOMOHIKO ICHIKAWA, SATORU TAKAHASHI, HIROAKI SHIINA, KATSUYOSHI HASHINE, YUTAKA SUGIYAMA, MANABU KAMIYAMA, HIDEKI ENOKIDA and KENICHI NAKAJIMA

Anticancer Research March 2022, 42 (3) 1465-1475; DOI: https://doi.org/10.21873/anticanres.15617
You have access
Health-related Quality of Life in Intermediate- or High-risk Patients Treated With Radical External Radiotherapy and Adjuvant Docetaxel for Localized Prostate Cancer: A Randomized, Phase III SPCG-13 Study
MIIKKA LEHTONEN, JORMA SORMUNEN, MARIE HJÄLM-ERIKSSON, CAMILLA THELLENBERG-KARLSSON, TEPPO HUTTUNEN, CLAES GINMAN, PIRKKO-LIISA KELLOKUMPU-LEHTINEN and On Behalf of the Investigators of the Scandinavian Prostate Cancer Group Study No 13

Anticancer Research January 2022, 42 (1) 87-92; DOI: https://doi.org/10.21873/anticanres.15460
You have access
Comparison of Treatment Completion Rate Between Conventional and Dose-dense Doxorubicin and Cyclophosphamide (AC) Followed by a Taxane in Patients With Breast Cancer: A Propensity Score-matched Analysis
KANAKO MAMISHIN, YOICHI NAITO, SHOGO NOMURA, GAKUTO OGAWA, KUMI NIGUMA, KAEDE BABA, SAEKO SAKAEDA, HIROMICHI NAKAJIMA, SHOTA KUSUHARA, CHIKAKO FUNASAKA, TAKEHIRO NAKAO, YOKO FUKASAWA, CHIHIRO KONDOH, KENICHI HARANO, TAKAHIRO KOGAWA, NOBUAKI MATSUBARA, AKO HOSONO, TOSHIKATSU KAWASAKI and TORU MUKOHARA

Anticancer Research December 2021, 41 (12) 6217-6224; DOI: https://doi.org/10.21873/anticanres.15441
You have access
Synergistic Antitumor Effect of Taxanes and CDK4/6 Inhibitor in Lung Cancer Cells and Mice Harboring KRAS Mutations
KYOUNG-HWA SON, MIN-YOUNG KIM, JUNG-YOUNG SHIN, JEONG-OH KIM and JIN-HYOUNG KANG

Anticancer Research October 2021, 41 (10) 4807-4820; DOI: https://doi.org/10.21873/anticanres.15296
You have access
Molecular Mechanism Mediating Cytotoxic Activity of Cabazitaxel in Docetaxel-resistant Human Prostate Cancer Cells
HIROMITSU WATANABE, ASUKA KAWAKAMI, RYO SATO, KYOHEI WATANABE, YUTO MATSUSHITA and HIDEAKI MIYAKE

Anticancer Research August 2021, 41 (8) 3753-3758; DOI: https://doi.org/10.21873/anticanres.15167
Open Access
Oral-recombinant Methioninase Converts an Osteosarcoma from Docetaxel-resistant to -Sensitive in a Clinically-relevant Patient-derived Orthotopic-xenograft (PDOX) Mouse Model
YUSUKE AOKI, YASUNORI TOME, NATHANIEL F. WU, JUN YAMAMOTO, KAZUYUKI HAMADA, QINGHONG HAN, MICHAEL BOUVET, KOTARO NISHIDA and ROBERT M. HOFFMAN

Anticancer Research April 2021, 41 (4) 1745-1751; DOI: https://doi.org/10.21873/anticanres.14939
Open Access
Modified TPEx as First-line Treatment for Recurrent and/or Metastatic Head and Neck Cancer
MOTOYUKI SUZUKI, YUKINORI TAKENAKA, TOSHIHIRO KISHIKAWA, YOSHIFUMI YAMAMOTO, ATSUSHI HANAMOTO, YOICHIRO TOMIYAMA, TAKAHITO FUKUSUMI, TAKAHIRO MICHIBA, NORIHIKO TAKEMOTO, SUSUMU NAKAHARA and HIDENORI INOHARA

Anticancer Research April 2021, 41 (4) 2045-2051; DOI: https://doi.org/10.21873/anticanres.14973
You have access
Hyperthermia During Intraperitoneal Chemotherapy With Paclitaxel or Docetaxel for Ovarian Cancer: Is There Any Benefit?
EELCO DE BREE, DESPOINA KATSOUGKRI, HARA POLIOUDAKI, ELENA TSANGARIDOU, DIMOSTHENIS MICHELAKIS, ODYSSEAS ZORAS and PANAYIOTIS THEODOROPOULOS

Anticancer Research December 2020, 40 (12) 6769-6780; DOI: https://doi.org/10.21873/anticanres.14700
You have access
Comparison of Tolerability Between 2-Weekly and 3-Weekly Docetaxel Regimen in Castration-resistant Prostate Cancer
YUSUKE SHIMURA, YUKIO SUGA, SHINGO ITAI, HIROAKI IWAMOTO, YUTA TAKEZAWA, HIROSHI YAEGASHI, KOUJI IZUMI, TSUTOMU SHIMADA, YOSHIMICHI SAI, RYO MATSUSHITA and ATSUSHI MIZOKAMI

Anticancer Research August 2020, 40 (8) 4291-4297; DOI: https://doi.org/10.21873/anticanres.14431

Main menu

User menu

Search

docetaxel

Pages